9-13150532-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001378778.1(MPDZ):āc.3609A>Gā(p.Lys1203Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.339 in 1,568,516 control chromosomes in the GnomAD database, including 95,194 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.42 ( 14582 hom., cov: 31)
Exomes š: 0.33 ( 80612 hom. )
Consequence
MPDZ
NM_001378778.1 synonymous
NM_001378778.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.31
Genes affected
MPDZ (HGNC:7208): (multiple PDZ domain crumbs cell polarity complex component) The protein encoded by this gene has multiple PDZ domains, which are hallmarks of protein-protein interactions. The encoded protein is known to interact with the HTR2C receptor and may cause it to clump at the cell surface. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 9-13150532-T-C is Benign according to our data. Variant chr9-13150532-T-C is described in ClinVar as [Benign]. Clinvar id is 158891.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.31 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.614 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPDZ | NM_001378778.1 | c.3609A>G | p.Lys1203Lys | synonymous_variant | 25/47 | ENST00000319217.12 | NP_001365707.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MPDZ | ENST00000319217.12 | c.3609A>G | p.Lys1203Lys | synonymous_variant | 25/47 | 5 | NM_001378778.1 | ENSP00000320006.7 |
Frequencies
GnomAD3 genomes AF: 0.417 AC: 63190AN: 151476Hom.: 14559 Cov.: 31
GnomAD3 genomes
AF:
AC:
63190
AN:
151476
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.345 AC: 79984AN: 232134Hom.: 14769 AF XY: 0.343 AC XY: 43478AN XY: 126754
GnomAD3 exomes
AF:
AC:
79984
AN:
232134
Hom.:
AF XY:
AC XY:
43478
AN XY:
126754
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.331 AC: 468960AN: 1416922Hom.: 80612 Cov.: 33 AF XY: 0.331 AC XY: 233149AN XY: 703842
GnomAD4 exome
AF:
AC:
468960
AN:
1416922
Hom.:
Cov.:
33
AF XY:
AC XY:
233149
AN XY:
703842
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.417 AC: 63261AN: 151594Hom.: 14582 Cov.: 31 AF XY: 0.417 AC XY: 30864AN XY: 74058
GnomAD4 genome
AF:
AC:
63261
AN:
151594
Hom.:
Cov.:
31
AF XY:
AC XY:
30864
AN XY:
74058
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1597
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 08, 2013 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at